Philips showcases commitment to improving respiratory care at ERS 2019
September 27 2019 - 04:00AM
Philips showcases commitment to improving respiratory care at ERS
2019
September 27, 2019
Broad portfolio of integrated sleep and respiratory solutions
connect data, technology and people across the care continuum
Amsterdam, the Netherlands and Madrid, Spain –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health
technology, will showcase its commitment to improving care for
hundreds of millions of patients worldwide living with chronic
sleep and respiratory conditions in its 17th appearance at the
European Respiratory Society (ERS) International Congress, taking
place September 28 - October 2, 2019, in Madrid, Spain.
“The rise of chronic conditions and the simple fact that the
global population is aging, present challenges across global
healthcare ecosystems already facing resource constraints amidst a
shifting technology landscape,” said Eli Diacopoulos, Business
Leader of Respiratory Care at Philips. “At Philips, we’re committed
to meeting those challenges by equipping providers, clinicians and
patients with the tools and information needed to provide the best
care experience possible. To do that, it’s essential to continue to
develop integrated technologies that make it easier to share,
analyze and use data, to help clinicians make better informed
decisions, reduce costs and readmissions and ultimately improve
patient care.”
At ERS, Philips will spotlight its broad portfolio of connected
solutions and services designed to address the needs of patients
with chronic sleep and respiratory conditions and help health
systems achieve the Quadruple Aim of value-based healthcare: an
improved experience for patients and staff, improved patient
outcomes, better health outcomes and a lower cost of care.
Featured solutions include innovative non-invasive
ventilation (NIV) device therapies, nebulizers, portable oxygen
concentrators, obstructive sleep apnea therapy solutions –
including new options for positional sleep apnea patients – and new
consumer sleep technologies.
Philips will also showcase its robust connected care platform,
which helps to enable providers and physicians to more effectively
manage patient care in a single platform, while providing patients
with more active engagement with their own health and therapy. Each
solution and service showcased at ERS has been developed based on
nearly 40 years of clinical expertise and a customer-first
mindset.
In addition to showcasing its growing portfolio of sleep and
respiratory solutions, Philips will also present multiple clinical
abstracts on topics ranging from cost of care to Expiratory Flow
Limitation. Philips will also lead three industry practical
workshops during the show:
- Sunday, September 29, 1:15 pm, Room N101+102
- “Expiratory Flow Limitation,” chaired by Dr. David White, chief
scientific officer, Sleep and Respiratory Care for Philips
- Monday, September 30, 1:15 pm, Room N101+102
- “Central Sleep Apnea Management and Use of Artificial
Intelligence in Sleep Stage Scoring,” chaired by Dr. David White,
chief scientific officer, Sleep and Respiratory Care for Philips,
and Prof. Michael Arzt University Hospital, Regensburg,
Germany
- Tuesday, October 1, 1:15 pm Room N101+102
- “New Principles in the Continuum of COPD Management,” chaired
by Dr. Teofilo Lee-Chiong, chief medical liaison, Sleep and
Respiratory Care for Philips, and Dr. Nicholas Hart professor and
clinical director of Lane Fox Respiratory Service, St Thomas’
Hospital in London
To experience Philips’ portfolio of sleep and respiratory
products, visit booth #S08 at ERS 2019. For updates on Philips’
presence at the show or more information on Philips’ advanced
solutions for sleep and respiratory care, follow @PhilipsResp or
visit Philips.com/At-ERS-Congress.
For further information, please contact:
Kathy O'Reilly Philips Global Press Office Tel: +1
978-221-8919 E-mail: kathy.oreilly@philips.comTwitter:
@kathyoreilly
Meredith Amoroso Philips Sleep and Respiratory Care Mobile: +1
724-584-8991
E-mail: meredith.amoroso@philips.com
About Royal PhilipsRoyal Philips (NYSE: PHG,
AEX: PHIA) is a leading health technology company focused on
improving people's health and enabling better outcomes across the
health continuum from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2018 sales of EUR 18.1 billion and
employs approximately 78,000 employees with sales and services in
more than 100 countries. News about Philips can be found
at www.philips.com/newscenter.
- Monitoring patient data to improve patient outcomes
- Connecting people, physicians and payers
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Mar 2023 to Mar 2024